6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Point prevalence study of antimicrobial use among hospitals across Botswana; findings and implications

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          <p class="first" id="d6046558e348">Objective: There is an urgent need to undertake Point Prevalence Surveys (PPS) across Africa to document antimicrobial utilisation rates given high rates of infectious diseases and growing resistance rates. This is the case in Botswana along with high empiric use and extended prophylaxis to prevent surgical site infections (SSIs) Method: PPS was conducted among all hospital sectors in Botswana using forms based on Global and European PPS studies adapted for Botswana, including rates of HIV, TB, malaria, and malnutrition. Quantitative study to assess the capacity to promote appropriate antibiotic prescribing. Results: 711 patients were enrolled with high antimicrobial use (70.6%) reflecting an appreciable number transferred from other hospitals (42.9%), high HIV rates (40.04% among those with known HIV) and TB (25.4%), and high use of catheters. Most infections were community acquired (61.7%). Cefotaxime and metronidazole were the most prescribed in public hospitals with ceftriaxone the most prescribed antimicrobial in private hospitals. Concerns with missed antibiotic doses (1.96 per patient), high empiric use, extended use to prevent SSIs, high use of IV antibiotics, and variable infrastructures in hospitals to improve future antibiotic use. Conclusion: High antibiotic use reflects high rates of infectious diseases observed in Botswana. A number of concerns have been identified, which are being addressed. </p>

          Related collections

          Most cited references54

          • Record: found
          • Abstract: found
          • Article: not found

          Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem.

          Antimicrobial resistance is a global public health challenge, which has accelerated by the overuse of antibiotics worldwide. Increased antimicrobial resistance is the cause of severe infections, complications, longer hospital stays and increased mortality. Overprescribing of antibiotics is associated with an increased risk of adverse effects, more frequent re-attendance and increased medicalization of self-limiting conditions. Antibiotic overprescribing is a particular problem in primary care, where viruses cause most infections. About 90% of all antibiotic prescriptions are issued by general practitioners, and respiratory tract infections are the leading reason for prescribing. Multifaceted interventions to reduce overuse of antibiotics have been found to be effective and better than single initiatives. Interventions should encompass the enforcement of the policy of prohibiting the over-the-counter sale of antibiotics, the use of antimicrobial stewardship programmes, the active participation of clinicians in audits, the utilization of valid rapid point-of-care tests, the promotion of delayed antibiotic prescribing strategies, the enhancement of communication skills with patients with the aid of information brochures and the performance of more pragmatic studies in primary care with outcomes that are of clinicians' interest, such as complications and clinical outcomes.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data.

            Antibiotic drug consumption is a major driver of antibiotic resistance. Variations in antibiotic resistance across countries are attributable, in part, to different volumes and patterns for antibiotic consumption. We aimed to assess variations in consumption to assist monitoring of the rise of resistance and development of rational-use policies and to provide a baseline for future assessment. With use of sales data for retail and hospital pharmacies from the IMS Health MIDAS database, we reviewed trends for consumption of standard units of antibiotics between 2000 and 2010 for 71 countries. We used compound annual growth rates to assess temporal differences in consumption for each country and Fourier series and regression methods to assess seasonal differences in consumption in 63 of the countries. Between 2000 and 2010, consumption of antibiotic drugs increased by 36% (from 54 083 964 813 standard units to 73 620 748 816 standard units). Brazil, Russia, India, China, and South Africa accounted for 76% of this increase. In most countries, antibiotic consumption varied significantly with season. There was increased consumption of carbapenems (45%) and polymixins (13%), two last-resort classes of antibiotic drugs. The rise of antibiotic consumption and the increase in use of last-resort antibiotic drugs raises serious concerns for public health. Appropriate use of antibiotics in developing countries should be encouraged. However, to prevent a striking rise in resistance in low-income and middle-income countries with large populations and to preserve antibiotic efficacy worldwide, programmes that promote rational use through coordinated efforts by the international community should be a priority. US Department of Homeland Security, Bill & Melinda Gates Foundation, US National Institutes of Health, Princeton Grand Challenges Program. Copyright © 2014 Elsevier Ltd. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found
              Is Open Access

              Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey

              The Global Point Prevalence Survey (Global-PPS) established an international network of hospitals to measure antimicrobial prescribing and resistance worldwide. We aimed to assess antimicrobial prescribing and resistance in hospital inpatients.
                Bookmark

                Author and article information

                Contributors
                Journal
                Expert Review of Anti-infective Therapy
                Expert Review of Anti-infective Therapy
                Informa UK Limited
                1478-7210
                1744-8336
                June 24 2019
                July 03 2019
                July 2019
                July 03 2019
                : 17
                : 7
                : 535-546
                Affiliations
                [1 ] Department of Pharmacy, Nyangabgwe Hospital, Francistown, Botswana
                [2 ] Botswana Essential Drugs Action Program, Ministry of Health and Wellness, Gaborone, Botswana
                [3 ] Infection Prevention and Control Program, Nyangabgwe Hospital, Francistown, Botswana
                [4 ] Managed Care, AFA, Gaborone, Botswana
                [5 ] Department of Pharmacy, Letsholathebe II Memorial Hospital, Maun, Botswana
                [6 ] Lenmed Bokamoso Private Hospital, Mmopane, Botswana
                [7 ] Department of Pharmacy, Mahalapye District Hospital, Mahalapye, Botswana
                [8 ] Department of Pharmacy, Deborah Retif Memorial Hospital, Mochudi, Botswana
                [9 ] Department of Pharmacy, Scottish Livingstone Hospital, Molepolole, Botswana
                [10 ] Department of Pharmacy, Bobonong Primary Hospital, Bobonong, Botswana
                [11 ] Department of Pharmacy, Goodhope Primary Hospital, Gaborone, Botswana
                [12 ] Department of Pharmacy, Lethlakane Primary Hospital, Letlhakane, Botswana
                [13 ] Department of Pharmacy, Gweta Primary Hospital, Gweta, Botswana
                [14 ] School of Pharmacy, University of Botswana, Gaborone, Botswana
                [15 ] Division of Clinical Pharmacology, Karolinska Institute, Karolinska University Hospital Huddinge, Huddinge, Sweden
                [16 ] Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK
                [17 ] Health Economics Centre, Liverpool University Management School, Liverpool, UK
                [18 ] School of Pharmacy, Sefako Makgatho Health Sciences University, Garankuwa, South Africa
                [19 ] Department of Biomedical Sciences, Faculty of Medicine, University of Botswana, Gaborone, Botswana
                Article
                10.1080/14787210.2019.1629288
                31257952
                67c62e6f-cebf-46cb-9043-e42c49876442
                © 2019

                http://creativecommons.org/licenses/by-nc-nd/4.0/

                History

                Comments

                Comment on this article